Longstanding insulin dependent diabetics may not require insulin after the introduction of GLP-1 analogues

Glucagon like peptide (GLP-1) analogues are a relatively novel medication developed primarily for the treatment of type 2 diabetes since 2005. Although GLP-1 analogues have been shown to be more effective in the first few years of diagnosis in type 2 diabetes, we report a case of a patient with long...

Descripción completa

Detalles Bibliográficos
Autores principales: Raja, Umar Y, Eastaugh, Alison E, Younas, Mohammed S, Hanif, Wasim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359167/
https://www.ncbi.nlm.nih.gov/pubmed/26668738
http://dx.doi.org/10.1177/2048004015576008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359167/
https://www.ncbi.nlm.nih.gov/pubmed/26668738
http://dx.doi.org/10.1177/2048004015576008

Ejemplares similares